|
Mr. May, the former Treasurer of Amgen (one of the world's largest biotechnology companies), initially joined Phase III Medical to assist with licensing activities in September 2003. In March of 2006, he was appointed the Company's Chief Financial Officer. For the last 20 years, Mr. May has worked in the areas of life science and biotechnology. From 1983 to 1998, Mr. May worked for Amgen as Corporate Controller (1983 to 1988), Vice President/Corporate Controller/Chief Accounting Officer (1988 to 1997), and Vice President/Treasurer (1997 to 1998). At Amgen, Mr. May helped build Amgen's accounting, finance and IT organizations. From 1998 to 2000, Mr. May served as the Senior Vice President, Finance & Chief Financial Officer of Biosource International, Inc., a provider of biologic research reagents and assays. From 2000 to May 2003, Mr. May served as the Chief Financial Officer of Saronyx, Inc., a company focused on developing productivity tools and secure communication systems for research scientists. Prior to the acquisition of NeoStem, California by Phase III Medical, from August 2003 to January 2005, Mr. May served as the Chief Financial Officer of NeoStem (California). In March 2005, Mr. May was appointed CEO of NeoStem and in May 2005 he was elected to the Board of Directors of NeoStem (California). He received a Bachelor of Science degree in Business Administration & Accounting in 1971 from the University of Missouri. | 